Form 8-K

8-K — Corteva, Inc.

Accession: 0001193125-26-153947

Filed: 2026-04-14

Period: 2026-04-14

CIK: 0001755672

SIC: 0100 (AGRICULTURE PRODUCTION - CROPS)

Item: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Item: Regulation FD Disclosure

Item: Financial Statements and Exhibits

Documents

8-K — d57201d8k.htm (Primary)

EX-10.1 (d57201dex101.htm)

EX-99.1 (d57201dex991.htm)

EX-99.2 (d57201dex992.htm)

EX-99.3 (d57201dex993.htm)

GRAPHIC (g57201g0414070006162.jpg)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K

8-K (Primary)

Filename: d57201d8k.htm · Sequence: 1

8-K

false 0001755672 0001755672 2026-04-14 2026-04-14 0001755672 dei:OtherAddressMember 2026-04-14 2026-04-14

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of Earliest Event Reported): April 14, 2026

Corteva, Inc.

(Exact Name of Registrant as Specified in Its Charter)

Delaware

001-38710

82-4979096

(State or other jurisdiction

of Incorporation)

(Commission

File Number)

(I.R.S. Employer

Identification No.)

9330 Zionsville Road,

Indianapolis, Indiana 46268

974 Centre Road,

Wilmington, Delaware 19805

(Address of principal executive offices)(Zip Code)

(833) 267-8382

(Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading

Symbol(s)

Name of each exchange

on which registered

Common Stock, par value $0.01 per share

CTVA

New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 5.02

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

Corteva, Inc. (the “Company”) previously announced on October 1, 2025 its intent to separate its seed business (“SpinCo”) from its remaining crop protection business (“New Corteva”) into two independent, publicly traded companies through a tax-free spin-off (the “spin-off). On April 14, 2026, Corteva, Inc. (the “Company”) announced in a series of press releases the initial executive leadership teams for SpinCo and New Corteva.

As of April 10, 2026, it has been determined that effective at the spin-off, the following named executive officers of the Company will resign from the Company and become employees and officers of SpinCo as outlined in the table below:

Named Executive Officer

Current Position with the Company

Expected Position with Spin-Off

Charles V. Magro

Chief Executive Officer

David P. Johnson

Executive Vice President, Chief Financial Officer

Chief Financial Officer

Samuel R. Eathington, Ph.D.

Executive Vice President, Chief Technology and Digital Officer

Chief Technology Officer

Judd M. O’Connor

Executive Vice President, Seed Business Unit

Chief Commercial and Operations Officer

On April 10, 2026, the Company’s board of directors appointed Luther (“Luke”) Kissam, age 61, the Chief Executive Officer of New Corteva effective at the spin-off. Prior to the spin-off, Mr. Kissam will join the Company June 1, 2026 as Chief Executive Officer of the Crop Protection Business Unit. Mr. Kissam most recently served as a Partner of Bernhard Capital Partners Management, LP, from January 2021 to September 2023 and Senior Advisor from September 2023 to July 2025. He previously served as President and CEO of Albemarle Corporation, a global specialty chemicals company with leading positions in lithium, bromine and refining catalysts, from September 2011 until his retirement in June 2020. He was also elected to its board of directors in 2011 and served as Chairman of its board from 2016 to June 2020, remaining a board member until May 2021. Mr. Kissam joined Albemarle in 2003 as Vice President, General Counsel and Corporate Secretary and served as Senior Vice President, Manufacturing and Law, and Corporate Secretary from January 2008 until his promotion to President in March 2010. Prior to joining Albemarle, Mr. Kissam served as President, General Counsel and Secretary of Merisant company, a manufacturer of artificial sweeteners. Mr. Kissam has served as a director of OGE Energy Corp. since 2020 and Advanced Drainage Systems, Inc. since 2024. Mr. Kissam joined the DuPont de Nemours, Inc. board of directors in June 2019, but will resign on or before June 1, 2026 as a condition of his employment with the Company.

Mr. Kissam and the Company entered into an employment agreement dated April 10, 2026 set forth in Exhibit 10.1 and incorporated herein by reference. Under the employment agreement, Mr. Kissam will receive an annual base salary of $1,200,000. Mr. Kissam will also have an annual short-term incentive opportunity each calendar year equal to 150% of his annual base salary (prorated for his hire date) and beginning in 2027 a long-term equity incentive with a target grant date value of $7,500,000 on terms provided to other executive employees. For 2026, Mr. Kissam will receive a one-time equity award with a target grant date value of $3,750,000 evenly split between performance stock units and restricted stock units. Under the agreement, Mr. Kissam is entitled to relocation assistance not to exceed $750,000.

Additionally, the Company effective with the spin-off will appoint Jeff Rudolph, age 43, Chief Financial Officer. Mr. Rudolph has served as the Company’s Senior Vice President, Chief Strategy Officer since June 2025, where he is responsible for leading enterprise strategy, mergers and acquisitions, economic and competitive intelligence, sustainability strategy and strategic enablement. Mr. Rudolph has served the Company and its heritage companies for 14 years, including most recently as Vice President, Finance for the Crop Protection business beginning in June 2022, where he supported the development and execution of the Crop Protection operations strategy to drive cost competitiveness and Corteva’s biologicals acquisitions. Prior to that, Mr. Rudolph served as Vice President, Investor Relations from December 2021 through June 2022.

The Company also appointed effective with the spin-off, Brook Cunningham, age 45, Chief Commercial Officer and Ralph Ford, age 47, Chief Integrated Operations Officer. Since June 2025, Ms. Cunningham has served as a Senior Vice President and President of Corteva Asia-Pacific, where she leads a commercial business spanning 17 countries. Prior to that Ms. Cunningham served as the Company’s Senior Vice President, Chief Strategy Officer since joining the Company in December 2022, where she led enterprise strategy, mergers and acquisitions, economic and competitive intelligence, sustainability strategy and strategic enablement. Prior to joining the Company, Ms. Cunningham spent over 12 years at the investment banking division of Lazard, Inc., most recently

as Managing Director and Head of Global Agribusiness and Nutrition from February 2017 to December 2022. Mr. Ford joined the Company in January 2023 as Vice President, Operations for Crop Protection and in April 2024 became Vice President, Integration Operations for Crop Protection. Prior to joining the Company, Mr. Ford spent over 17 years at Celanese Corporation in various global manufacturing and operational leadership roles, including most recently roles in Germany as Senior Director, Operations for Mergers & Acquisitions from June 2022 to January 2023 and as Senior Operations Director from January 2022 through June 2022.

As of April 10, 2026, Robert D. King, currently the Executive Vice President, Crop Protection Business Unit will transition to a strategic advisor role to Mr. Kissam effective July 1, 2026, to support a smooth management transition through the spin-off. To support this transition, Mr. King will continue with the Company through the 2026 year-end and will be eligible for a $1 million transition incentive bonus subject to the achievement of certain milestones established for this transition. The elimination of the Executive Vice President, Crop Protection Business Unit role is a qualifying termination event providing Mr. King eligibility for severance under the Company’s Change in Control and Executive Severance Plan incorporated herein by reference as Exhibit 10.2.

Cautionary Statement on Forward-Looking Statements

This report contains certain forward-looking statements. Words such as “intend,” “will,” “may,” and “expect,” and variations of such words and similar future or conditional expressions are intended to identify forward-looking statements. Examples of forward-looking statements include, but are not limited to, the Company’s intent to separate and its related expectations for New Corteva and SpinCo. These forward-looking statements reflect management’s current expectations and are not guarantees of future performance and are subject to a number of risks and uncertainties, many of which are difficult to predict and beyond the Company’s control.

Important factors that may affect the Company’s business and operations and that may cause actual results to differ materially from those in the forward-looking statements include, but are not limited to, whether the objectives of the spin-off will be achieved; the terms, structure, benefits and costs of any action or transaction resulting from the spin-off; the timing of any such spin-off or related action and whether any such spin-off will be consummated at all; the risk that the announcement of the intended spin-off could have an adverse effect on the ability of the Company to retain and hire key personnel and maintain relationships with customers, suppliers, employees, shareholders and other business relationships and on its operating results and business generally; the risk the spin-off could divert the attention and time of the Company’s management; the risk of any unexpected costs or expenses resulting from the spin-off process or spin-off itself; and the risk of any litigation relating to the spin-off, as well as the risks and uncertainties described in the Company’s risk factors, as they may be amended from time to time, set forth in its filings with the U.S. Securities and Exchange Commission. The Company disclaims and does not undertake any obligation to update, revise, or withdraw any forward-looking statement in this report, except as required by applicable law or regulation.

Item 7.01

Regulation FD Disclosure

The Company issued three news releases on April 14, 2026, announcing the chief executive officer of New Corteva and the new executive leadership teams for New Corteva and SpinCo. Copies of these news releases are furnished as Exhibits 99.1, 99.2, and 99.3. The Company is furnishing the information under this item, including Exhibits 99.1, 99.2, and 99.3, pursuant to Item 7.01, “Regulation FD Disclosure”.

Item 9.01

Financial Statements and Exhibits

(d) Exhibits.

10.1

Employment Agreement between Corteva, Inc. and Luke Kissam, dated April 10, 2026

10.2

Corteva, Inc. Change in Control and Severance Plan (incorporated by reference to Exhibit 10.2 to Corteva’s Current Report on Form 8-K (Commission file number 001-38710), filed on October 28, 2021)

99.1

Press Release dated April 14, 2026, announcing the new chief executive officer of New Corteva

99.2

Press Release dated April 14, 2026, announcing the new executive leadership team of New Corteva

99.3

Press Release dated April 14, 2026, announcing the new executive leadership team of SpinCo

104

The cover page from the Company’ Current Report on Form 8-K, formatted in Inline XBRL

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

CORTEVA, INC.

(Registrant)

/s/ Jennifer A. Johnson

Jennifer A. Johnson

Senior Vice President, Chief Legal and Public Affairs Officer, and Company Secretary

April 14, 2026

EX-10.1

Filename: d57201dex101.htm · Sequence: 2

EX-10.1

Exhibit 10.1

April 10, 2026

Luther

“Luke” Kissam

lukekissam@gmail.com

Dear Luke:

Corteva, Inc. (the “Company”) is pleased to offer you employment on the terms described in this letter agreement (this

“Agreement”).

1. Term. The term of this Agreement and your employment with the Company is expected to begin on

June 1, 2026 (your first day of employment, the “Hire Date”) and will continue until your employment terminates for any reason, except that the provisions of this Agreement will survive the termination of your employment as is necessary

to give effect to their express terms. You will become an employee of Corteva, Inc.

2. Title and Role.

a. From your Hire Date until the spinoff of the Company’s Seed business (currently anticipated, but not guaranteed, to occur on

October 1, 2026) you will serve as Chief Executive Officer of the Crop Protection Business Unit, reporting directly to Chuck Magro.

b. Immediately after the spinoff of the Company’s Seed business, you will serve as Chief Executive Officer of Corteva, Inc., reporting

directly to the Board of Directors of the Company (the “Board”). In such role, you will be the most senior executive of the Company to whom all other executives and employees of the Company report, directly or indirectly, and will

have all the duties and authorities customarily associated therewith. Promptly after the spinoff of the Company’s Seed business, the Board will appoint you to become a member of the Board.

c. You will devote substantially all your business time and attention to your duties hereunder, except for approved vacation and time-off periods and reasonable periods of illness or other incapacities permitted by the Company’s general employment policies. Nothing in this Agreement will prohibit or restrict you from engaging in civic,

charitable or religious activities or sitting on non-profit boards, in each case, provided such endeavors or service do not materially interfere with your obligations under this Agreement. You agree that prior

to your Hire Date, you will no longer serve as a director on the board of directors of DuPont. In addition, you will not join the board of directors of any for- profit company without the prior approval of the Board; provided that you will not serve

on more than one public company board in addition to the Board.

3. Location. Your primary work location will be at the Company’s

corporate headquarters in the United States. The Company is still in the process of determining the post-separation headquarters of the Company.

4. Base Salary. You will receive a base salary at the annual rate of USD1,200,000, payable in accordance with the Company’s

regular payroll practices.

5. Annual Cash Bonus. With respect to each calendar year, you will be eligible to receive an

annual cash bonus under the Company’s Performance Reward Program (an “Annual Bonus”). Your target Annual Bonus opportunity each calendar year will be equal to 150% of your annual base salary, except that your target Annual Bonus

opportunity for 2026 will be prorated based on the Hire Date. Your right to payment of each Annual Bonus will be conditioned on the Board’s certifying the achievement of the goals established for the applicable calendar year and on your

continued employment at the time of the bonus payment. Payment of any earned Annual Bonus for a calendar year will be made no later than March 15th of the following calendar year.

6. Annual Equity Awards. With respect to each calendar year beginning with 2027, you will be eligible to participate in the

long-term incentive and equity plans of the Company with a target grant date value (determined using the Company’s customary methodology) of USD7,500,000. The type of awards granted to you each year, and the other terms and conditions thereof,

will be determined by the Board (or an appropriate committee thereof) and will be subject to the applicable terms and conditions of the Company’s 2019 Omnibus Incentive Plan, but will be consistent with the grants awarded to other senior

executives of the Company.

7. One-Time Off-Cycle LTI

Award. You will receive a USD3,750,000 off-cycle 2026 annual award on your Hire Date (50% PSU / 50% RSU). Additional details will be provided in the Award Terms, which you will receive after the awards

have been granted.

8. Benefit Plans. You will be eligible to participate in (a) the Company’s Retirement Savings

Plan, Retirement Savings Restoration Plan, Management Deferred Compensation Plan and (b) the Company’s standard employee benefit programs (including health and welfare) made available to other U.S. senior management employees, including

the executive health program and executive financial management program, in each case, subject to the terms and conditions of such programs. You will be eligible to receive up to twenty (20) days of Choice Time in each calendar year (except

that your Choice Time for 2026 will be prorated based on the Hire Date) and certain paid holidays. The Company reserves the right to amend any benefit plans or programs in accordance with their terms. For the avoidance of doubt, your participation

in such programs will be on a basis that is no less favorable than any other senior executive of the Company. In addition, the Company will reimburse you for documented business expenses properly incurred by you on behalf of the Company in

accordance with the Company’s applicable business expense reimbursement policies.

9. Relocation Assistance. You will receive domestic relocation assistance in

accordance with the Company’s standard relocation policies (not eligible for guaranteed buyout or loss of sale benefits); provided that (a) as a condition to such assistance, you must provide the applicable documentation of any

reimbursable expense no later than January 30 of the year following the year in which such expense was incurred, (b) all reimbursements will be made no later than March 15 of the year following the year in which the applicable expense was

incurred, (c) upon your termination of employment for any reason, you will cease to be eligible for or receive any such assistance (other than reimbursement for expenses incurred prior to such termination) and (d) the aggregate value of all

allowances and reimbursements made to you will not exceed USD750,000.

10. Termination of Employment; Severance. You agree

that your employment with the Company is not for any specific duration or period of time and that you are an employee at-will. Your employment may be terminated at any time by you or the Company, with or

without cause and with or without notice. Notwithstanding the foregoing, effective as of the Hire Date, you will participate in the Company’s Change in Control and Executive Severance Plan, as in effect from time to time, as the

“CEO” (as defined therein), which will govern the termination of your employment and any payments or benefits to which you may be entitled as a result thereof. You are eligible under the plan to be eligible for certain severance

protections upon a Qualifying Termination, which includes either termination of employment by the Company without cause or Good Reason, which has the meaning assigned to such term or an analogous term in any individual service, employment or

severance agreement or Award Agreement with the Participant or, if no such agreement exists or if such agreement does not define “Good Reason” or an analogous term, then “Good Reason” shall mean (i) a material diminution

in the Participant’s base compensation, (ii) a material diminution in the Participant’s authority, duties, or responsibilities, or (iii) a material change in the geographic location at which the Participant must perform his/her

services for the Company.

11. Other Matters.

a. You acknowledge and agree that, as a condition of your employment hereunder, you will execute and deliver the Company’s standard

employee agreement, in the form attached hereto as Schedule A, to be effective as of the Hire Date. In addition, you acknowledge and agree that you will comply with any ongoing confidentiality or other restrictive covenant obligations that

you may have with any former employer..

b. You will be entitled to the same director and officer indemnification provided to other

executive officers pursuant to the Company’s Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws. In addition, you will be provided coverage under the Company’s director and officer insurance policy on the

same basis as the other executive officers of the Company.

c. You acknowledge and agree that you are subject to the Company’s

policies for executives and for employees generally, as amended from time to time, including, without limitation, the Company’s insider trading policy, stock ownership policy, compensation recovery policy and code of ethics.

d. Following the termination of your employment with the Company, you acknowledge and agree

that you will cooperate with requests of the Company regarding any legal matters or proceedings of any kind, which will include making yourself available for interviews or testimony if reasonably requested by the Company. The Company will reimburse

you for any reasonable expenses incurred in connection with such requests or assistance if approved by the Company and supported by required documentation. No payment made to you hereunder is intended to be or will be interpreted as payment for any

particular testimony or assistance with respect to the legal matters specified above or any other matter. You understand that you are to provide your good faith assistance and agree to provide truthful responses to any requests for information or

testimony.

e. As is customary, this offer is contingent upon: (i) successful completion of

pre-employment screening, including a drug screen and background check. In some instances, a medical evaluation or other required screening must be successfully completed within Corteva’s guidelines,

(ii) presentation of sufficient document(s) to complete the I-9 Employment Eligibility Verification establishing your identity and employment eligibility as required by the Immigration Reform and Control

Act of 1986 which makes it unlawful for an employer to hire an individual not authorized for employment in the U.S. Please see link for acceptable documentation:

https://www.uscis.gov/i-9-central/acceptable-documents), (iii) completion of the Company Director’s Officer and Officers Questionnaire and confirmation that

you are free of conflicts of interest, and (iv) certification that you have read and will comply with the Company’s Code of Conduct.

12. Miscellaneous.

a. Governing Law. The validity, interpretation, construction and performance of this Agreement, and all acts and transactions

pursuant hereto and the rights and obligations of the parties hereto will be governed, construed and interpreted in accordance with the laws of the State of Delaware, without giving effect to principles of conflicts of law. Unless otherwise

prohibited by law, you and the Company agree to have any disputes arising out of this Agreement resolved in a forum having a substantial body of law and experience, so both you and the Company agree that any action or proceeding arising out of this

Agreement will be brought exclusively in the state or federal courts of Delaware and both you and the Company further agree to the personal jurisdiction of those courts. Both you and the Company waive any objection that either party may now or later

have to the venue of any such action in such court(s), and further both you and the Company waive any claim that either party may now or later have that any action brought in such court(s) has been brought in an inconvenient forum.

b. Entire Agreement. This Agreement sets forth the entire agreement and understanding of the parties relating to the subject

matter herein and supersedes all prior or contemporaneous discussions, understandings, term sheets and agreements, whether oral or written, between you and the Company relating to the subject matter hereof. No amendment, modification or change to

this Agreement will be enforceable unless reduced to writing and executed by both you and the Company.

c. Taxes. All amounts payable to you hereunder will be subject to any

applicable tax withholdings or deductions. This Agreement is intended to comply with Section 409A of the Internal Revenue Code (“Section 409A”) or an exemption thereunder and will be construed and administered in accordance with

Section 409A. Payments provided under this Agreement may only be made upon an event and in a manner that complies with Section 409A or an applicable exemption. For purposes of Section 409A, each installment payment provided under this

Agreement will be treated as a separate payment. Any payments to be made under this Agreement that constitute “deferred compensation” within the mention of Section 409A upon a termination of employment will only be made upon a

“separation from service” within the meaning of Section 409A. To the extent required under Section 409A, amounts that would otherwise be payable under this Agreement during the six (6) month period immediately following

Employee’s separation from service shall instead be paid on the first business day after the date that is six (6) months following Employee’s separation from service (or, if earlier, Employee’s date of death). Any

reimbursements of expenses or in-kind benefits provided under this Agreement that are not otherwise exempt from Section 409A will comply with the requirements of Treasury Regulation Section l.409A-3(i)(l)(iv) (or successor provisions). The amount of any such expenses reimbursed, or benefits provided during one taxable year will not affect the amount of expenses eligible for payment or reimbursement in

any other taxable year. Any such expenses reimbursed, or benefits provided will be made on or before the last day of your taxable year following the taxable year in which the expense was incurred. Any such right to reimbursement or benefits is not

subject to liquidation or exchange for any other benefit. In the event of non-compliance with Section 409A, Employee shall be responsible for the payment of taxes, penalties, interest or other expenses.

d. Successors and Assigns. This Agreement will bind the heirs, personal representatives, successors and assigns of both you

and the Company, and inure to the benefit of both you and the Company, their heirs, successors and assigns.

To indicate your acceptance of

this Agreement, please sign and date this Agreement in the space provided below.

Very truly yours,

CORTEVA, lNC.

By:

/s/ Gregory R. Page

Gregory R. Page

Chair, Corteva Board of Directors

ACCEPTED AND AGREED:

By:

/s/ Luke Kissam

Luke Kissam

Schedule A

EMPLOYEE AGREEMENT

This is my Employee Agreement (“Agreement”) with Corteva, Inc. and its affiliated, subsidiary, and successor companies (the

“Company”).

In consideration for my employment with the Company, and the financial and other benefits I receive from that

employment, the Company and I agree as follows:

1. Employment at Will: My employment with the Company is not for any

specific duration or period of time, and I am an employee at-will of the Company. This means that the employment relationship between the Company and me may be terminated by either of us at any time, with or

without cause and with or without notice.

2. Application of Agreement to Affiliates, Subsidiaries, and/or Successors and Changes in

Position: This Agreement and my commitments under it will apply with and are assigned by the Company to its affiliates, subsidiaries, or successors in connection with my work for or employment with those affiliates, subsidiaries, or

successors. I understand that this Agreement will continue to apply even as my job duties and compensation change during my employment. All references in this Agreement to “the Company” apply equally to any affiliated or successor entity

by which I am employed.

3. Duty of Loyalty: During my employment with the Company, I will devote my full work time, energy,

and best efforts to the business of the Company. I will avoid conflicts of interest, comply with the Company’s policies, and its Code of Conduct.

4. Inventions and Discoveries: I will promptly identify and fully disclose to the Company’s HR and/or Legal

Intellectual Property Function all inventions, copyright eligible works, ideas, improvements, software, discoveries, and other intellectual property that I develop, discover, or create that: (i) relate to the Company’s business, or to any

actual or demonstrably anticipated research, future work, or projects of the Company, whether or not conceived or developed alone or with others, and whether or not conceived or developed during regular working hours; or (ii) result from any

work that I have performed for the Company, performed on Company time, or performed using the Company’s property or resources. These works and materials described in subsections (i) and (ii) of this Section 4(a) are referred to as

“Company Inventions and Intellectual Property.” All Company Inventions and Intellectual Property, and the rights to them, moral and otherwise, are and will remain as the Company’s exclusive property unless otherwise agreed by both

me and the Company in writing. While employed, and as necessary after my employment ends, I agree that I will assist the Company in obtaining patents or copyrights on all Company Inventions and Intellectual Property that that Company seeks to

protect and execute all documents and do everything requested of me to assist the Company in pursuing and securing the complete benefits of Company’s Inventions and Intellectual Property. I hereby assign to the Company or its designee all

rights, title, and interest to all Company Inventions or Intellectual Property that I have conceived, developed, discovered, or created or will develop, discover or create in the future during my employment or association with the Company.

(a) I represent and warrant that I have disclosed to the Company all intellectual property

in which I had an ownership interest prior to the commencement of my employment with the Company.

(b) To the extent that the state

law where I reside requires it, this is my notice that no provision in this Agreement requires me to assign any of my rights to an invention for which no equipment, supplies, facility, or Confidential Information of the Company was used and which

was developed entirely on my own time, unless: (i) the invention relates at the time of conception, or reduction to practice of the invention, to the business of the Company or to the Company’s actual or demonstrably anticipated research

or development; or (ii) the invention results from any work performed by me for the Company.

5. Confidential Information:

I acknowledge that during my employment with the Company, I will come into contact with and learn various forms of Confidential Information and Trade Secrets,

as defined below, which are the property of the Company. Confidential Information and Trade Secrets are items of information relating to the Company that are of great competitive value to the Company, which may be disclosed to me or of which I may

become aware because of my relationship with the Company, which are not generally known or available to the general public or the Company’s competitors, and which have been developed, compiled, or acquired by the Company at its great effort

and expense. “Confidential Information” includes, but is not limited to:

(1)

financial and business information,1

(2)

product and technical information,2

(3)

marketing information,3

(4)

customer and prospective customer information,4 and

(5)

employees, contractors, and consultants’ skills and abilities, and other personnel information.5

Some examples of financial and business information include information with respect to costs, commissions,

fees, profits, sales, sales margins, capital structure, operating results, borrowing arrangements, strategies and plans for future business, pending projects and proposals, and potential acquisitions or divestitures.

Some examples of product and technical information include new and innovative ideas, research and development

projects, investigations, new business development, trademarks and brand names under development, sketches, plans, drawings, prototypes, methods, procedures, manufacturing processes, sourcing, experimental and testing results, devices, machines,

equipment, data processing programs, software, software codes, and computer models.

Some examples of marketing information include new marketing ideas, strategies, initiatives, business plans,

markets, and mailing lists.

Some examples of customer information include the identity of the Company’s customers and prospective

customers, their names, the names of representatives of the Company’s customers and prospective customers responsible for entering into contracts with the Company, the financial arrangements between the Company and its customers, the existence

and terms of contracts with customers orany future contracts with customers or prospective customers, specific needs, requirements, and preferences of customers, and leads and referrals to certain prospective customers.

Examples ofpersonnel information may include theidentity and number of the Company’s employees,

consultants, and contractors; contractor or consultant billing rates; qualifications; and performance metrics.

(a) “Trade Secrets” are a subset of Confidential

Information that meet the requirements of applicable federal and/or state trade secret law. Confidential Information and Trade Secrets can be in any form, including, without limitation, oral, written, machine readable, or digital.

(b) Throughout my employment with the Company and at all times following the end of my employment, whether voluntary or involuntary: (i) I

will hold all Confidential Information and Trade Secrets in the strictest confidence, take all reasonable precautions to prevent inadvertent disclosure to any unauthorized person, and follow all Company policies protecting Confidential Information

and Trade Secrets; (ii) I will not, directly or indirectly, use, disclose, or make available to any other person or entity any Confidential Information or Trade Secrets other than in the proper performance of my duties during my employment with

the Company; and (iii) I will not use the Company’s Confidential Information or Trade Secrets to attempt to solicit, induce, recruit, or take away clients or customers of the Company. I understand and acknowledge that my

confidentiality obligations will terminate only if and when the Confidential Information or Trade Secrets in question become generally known to the public through no wrongful act by me or others who are under confidentiality obligations.

(c) Nothing in this Agreement prohibits me from disclosing information in connection with the exercise of any legally protected right. I am not

prevented from filing a charge with or participating, testifying, or assisting in any investigation, hearing, whistleblowing proceeding, or other proceeding before any federal, state, or local government agency. Also, under the federal Defend Trade

Secrets Act of 2016, I will not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that: (a) is made (i) in confidence to a federal, state, or local government official,

either directly or indirectly, or to an attorney; and (ii) solely for the purpose of reporting or investigating a suspected violation of law; or (b) is made to the attorney defending me in a lawsuit for retaliation against me for reporting

a suspected violation of law; or (c) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.

6. Return of Company Property: Immediately, or as soon as practicable, upon the end of my employment or at any time the Company

requests, I agree to return to the Company any and all property belonging to it that is in my possession or under my control.6

Examples of Company property include, without limitation, all computers and computer equipment; office

equipment; phones provided by the Company; vehicles and keys assigned to me by the Company; office keys, passes, and passcards; documents (whether in hard copy of electronic form), books, and notebooks; and computer files, databases, programs, thumb

drives, external drives, disks, and computer access codes.

7. Post-Employment Covenants: In addition to my ongoing confidentiality

obligations in Section 5, I agree to the following covenants that will survive the end of my employment with the Company (“Post-Employment Covenants”).

(a) Non-Competition Covenant: The Company is engaged in a highly competitive global

business, and I understand and acknowledge that through my position and responsibilities in the Company, I may gain business knowledge such that if I engage in a business that directly competes with the Company, it may cause the Company great and

irreparable harm. Therefore, subject to any state or local law, or rule, that may apply to me, I agree that for a period of one (1) year after my employment with the Company ends, whether it ends voluntarily or involuntarily, the Company has

the right, in its sole discretion, to require that I not directly or indirectly perform for any Competing Business the same or similar duties that I performed for the Company7 during the two

(2) years preceding the end of my employment (“Exercise the Non-Compete” or “Exercise of Non-Compete”). A “Competing

Business” means any individual or entity that develops, manufactures, sells, and/or distributes a product or service that competes with those products or services offered or under development by the Company. Although the Company conducts

business globally, this Non-Competition Covenant will apply only to those regions, states and territories of the United States of America, and, if applicable, those countries of the world outside of the United

States of America, in which I was employed or had responsibility within the last two (2) years of my employment.

(b) Notice to

Company: During and for the one (I) year period following the end of my employment, whether voluntary or involuntary, I must provide written notice to the Company of any offers of employment that I intend to accept, including the name

of the potential new employer and a description of the role that I have been offered. This information shall be submitted the HR Direct Service Center with a copy to my former Company leader. The Company will have ten (10) days to

consider whether my new employment opportunity: (i) involves the same or similar duties that

Generally, the same or similar duties that I would be restricted from performing for a Competing Business might

involve current or developing products, services, manufacturing, research and development, and any other strategic role: (a) for which I had responsibility or worked with in the last two (2) years of my employment, or (b) about which

I acquired knowledge of or access to Confidential Information and Trade Secrets in the last two (2) years of my employment.

I performed for the Company during the last two years of my employment and (ii) is for a Competing

Business, such that the Company needs to Exercise the Non-Compete. I agree to immediately provide the Company with any additional information that it may request in order to analyze whether my new employment

opportunity poses a competitive risk to the Company’s business interests. The Company has the sole discretion to determine whether or not to Exercise the Non-Compete with respect to my new job

opportunity.

Customers: For a period of one (1) year after my employment with the Company ends, whether voluntarily or involuntarily, I will not directly or indirectly solicit, contact, or communicate with (regardless of who initiates the communication)

customers of the Company for the purpose of inducing or encouraging customers to stop or reduce doing business with the Company or in an attempt to sell or provide any product or service that competes with those products or services offered by the

Company. “Customers” in this Section means only those customers, prospective customers, and end users (i.e., customers of retailers or dealers) of the Company: (i) with whom I had personal contact within the last two

(2) years of my employment, or (ii) about whom I learned Confidential Information or Trade Secrets during the last two (2) years of my employment with the Company.

(d) Non-Solicitation of Employees: For a period of one (1) year after my employment

with the Company ends, whether voluntarily or involuntarily, I will not directly or indirectly interfere with the Company’s relationship with its employees by (a) soliciting or communicating with an employee to induce or encourage him or

her to leave the Company’s employ (regardless of who first initiates the communication); (b) helping another person or entity evaluate a Company employee as an employment candidate; or (c) otherwise helping any person or entity hire an

employee away from the Company. This restriction applies only to employees: (i) I worked with or supervised, or (ii) about whom I learned Confidential Information during the last two (2) years of my employment with the Company.

(e) Non-Interference with Business Partners: For a period of one (I) year after my

employment with the Company ends, whether voluntarily or involuntarily, I will not directly or indirectly interfere with, disrupt, or attempt to disrupt the Company’s relationship, contractual or otherwise, with its vendors, suppliers,

contractors, and consultants (collectively “Business Partners”) or diminish or attempt to diminish the services being provided to the Company by any Business Partners where permitted by law. This restriction shall apply only to those

Business Partners of the Company with whom I came into contact during the last two (2) years of my employment with the Company.

8. Enforcement: If litigation or other formal action is required to enforce

this Agreement, I agree that the prevailing party shall be entitled to recover its reasonable costs and attorney’s fees. Further, I understand that if I breach my Post-Employment Covenants, the restrictive periods will not continue to run and

will, instead, be tolled for the period of time that I am in breach. Accordingly, the restrictive periods will be extended for a period equal to the duration of my breach, where permitted by law. If any part of this Agreement is held void, illegal,

or unenforceable, or in conflict with any applicable law, every other term of this Agreement will remain valid and fully enforceable. If any court refuses to enforce any part of this Agreement as written, the court may modify that part to the

minimum extent necessary to make it enforceable under applicable law, and shall enforce it as modified.

9. Confidential Information

Belonging to Others: I affirm that I am not presently subject to a restrictive covenant or other contract or agreement of any kind that prohibits, restricts, or limits my employment with the Company, or, alternatively, that I have disclosed

such agreement to the Company prior to starting employment with the Company. If I later learn that I may be subject to a restrictive covenant or other prior agreement of which I am currently unaware that may prohibit or restrict my employment with

the Company, I will immediately notify the Company. If I have a restrictive covenant that interferes with my employment with the Company, the Company may elect to end my employment and enforce the restrictive covenants in this Agreement, but under

such circumstances, I will not be entitled to any compensation for the non-compete restrictions as set forth in Section 7(c) above. I also agree that I will not disclose to the Company, use for the

Company’s benefit, or induce the Company to use any trade secret or confidential information that I may possess or any intellectual property belonging to any former employer or other third party to whom I owe a duty of confidentiality.

10. Data Usage and Protection: I acknowledge and agree that in the ordinary course of business, the Company has or may be

collecting, processing, and storing (electronically or otherwise) certain family, personal, and personnel data in accordance with the Company’s Privacy Policy.

11. No Expectation of Privacy: I acknowledge and agree that during my employment with the Company, I have no expectation of

privacy with respect to the Company’s telecommunications, networking, or information processing systems (including, without limitation, stored files, e-mail messages, text messages, and voice messages).

I agree that at any time, without notice, the Company may monitor my use of such Company systems and any files or messages created, sent, or received by me on any of those systems. I agree that any property owned by the Company and any of my

property located on Company’s premises, including disks, other storage media, filing cabinets, lockers, vehicles, and work areas, are subject to inspection by the Company at any time, without notice.

12. Entire Agreement: This Agreement supersedes any prior employee agreements that I may have with Corteva, Inc. or any

affiliated predecessor company, including but not limited to Dow AgroSciences LLC, E.I. du Pont de Nemours and Company, and Pioneer Hi-Bred International, except to the extent I have an ongoing

obligation of confidentiality to such predecessor. In addition, to the extent the Post-Employment Covenants in this agreement conflict with or are different from any agreements regarding equity

awards that I may have with Corteva, Inc. or any affiliated predecessor company, the terms in my equity award agreement will control in such circumstance. I acknowledge that I have not relied on any representations, promises, or agreements of any

kind made to me in connection with my acceptance of this Agreement, except for those set forth in this Agreement. I also understand that I am free to consult an attorney before I sign the Agreement, if I choose to do so.

No amendment, modification, or waiver to this Agreement will be binding upon either me or the Company unless it is in writing and signed by both of us.

13. Governing Law and Choice of Forum: This Agreement shall be governed by, and construed in accordance with, the laws of

the State of Delaware, without regard to its conflict of laws provisions. Unless otherwise prohibited by law, the Company and I desire to have any disputes arising out of this Agreement resolved in a forum having a substantial body of law and

experience, so we agree that any action or proceeding arising out of this Agreement shall be brought exclusively in the state or federal courts of Delaware, Iowa or Indiana, and we further agree to the personal jurisdiction of those courts. Both the

Company and I waive any objection we may now or later have to the venue of any such action in such court(s), and further we waive any claim we may now or later have that any action brought in such court(s) has been brought in an inconvenient forum.

14. Disclosure of Agreement: I agree that I will promptly disclose the existence of this Agreement and the Post-Employment

Covenants in it to all of my subsequent employers or prospective employers until all Post-Employment Covenants have expired.

15.

Electronic Signature: I received this Agreement electronically with sufficient time to review it, ask questions, and consult my attorney, if I chose to do so. I have also had the opportunity to download a copy of the Agreement and

understand that additional copies are available to me. I understand that checking my acknowledgement and agreement to the terms of this Agreement constitutes my electronic signature.

Signature:

Gregory Page

Luke Kissam

Email:

EX-99.1

Filename: d57201dex991.htm · Sequence: 3

EX-99.1

Exhibit 99.1

Corteva Announces CEO of its Future Crop Protection Company

Luke Kissam, former Chairman, President and CEO of Albemarle, joins company on June 1

Indianapolis, Ind., April 14, 2026 – Corteva Inc. (NYSE: CTVA) announced today that its Board of Directors has named Luther (“Luke”)

Kissam the chief executive officer of “New Corteva,” the future publicly-traded, differentiated crop protection company resulting from the current company’s planned separation in the fourth quarter of 2026.

New Corteva will be innovation-driven in both its product portfolio and its operating model, leveraging its technological leadership to deliver for farmers

while also running an asset-light, efficient business. The company intends to make targeted investments to support growth and leverage its first-mover advantage in nature-inspired technologies to pursue opportunities promising attractive returns in

markets that reward differentiation.

Luke will join Corteva on June 1 as CEO of its crop protection business, becoming CEO of the new, public

company at separation, which is on track for the fourth quarter of 2026.

“Over the past several months, we have conducted

a comprehensive search and assessment of many strong candidates, and we appointed Luke because it is clear that he is the right leader to continue to strengthen New Corteva’s position as a global market leader in the

dynamic, competitive crop protection industry,” said Corteva Chair Greg Page. “Luke’s track record of propelling public companies towards sustained, innovation-led growth and integrated,

market-focused solutions will serve farmers, customers and shareholders equally well.”

Luke brings to the role extensive experience in

specialty chemicals as well as agriculture: he previously served as chairman, president and CEO of Albemarle Corporation, a global specialty chemicals leader, until his retirement from the company in June 2020. Luke joined

Albemarle in 2003 as vice president, general counsel and corporate secretary and served as senior vice president, manufacturing and law, and corporate secretary from 2008 until his promotion to president in 2010.

Prior to joining Albemarle, Luke served as vice president, general counsel and secretary of Merisant Company, having previously served as associate

general counsel at Monsanto. His most recent role was senior advisor at Bernhard Capital Partners Management.

“New Corteva will have every ingredient it needs to continue its upward trajectory: a talented

leadership team, knowledgeable, passionate employees and loyal customers who understand the difference innovation creates – on their fields and for their bottom line. I am excited to take the helm of a company poised for such

transformational success,” said Kissam.

He continued, “I grew up in a farming community, and that’s where I feel most at home. I

also value the critical role agriculture plays in our economy and our society. For all these reasons, it’s a pleasure to rejoin an industry delivering solutions to help farmers grow more food – and fuel – to power our

growing world.”

Members of New Corteva executive leadership will be hosting an investor day on September 15 at the New York Stock Exchange;

details on attendance and participation will be shared in the coming weeks.

About Corteva

Corteva, Inc. (NYSE: CTVA) is a global pure-play agriculture company that combines industry-leading innovation, high-touch customer engagement and operational

execution to profitably deliver solutions for the world’s most pressing agriculture challenges. Corteva generates advantaged market preference through its unique distribution strategy, together with its balanced and globally diverse mix of

seed, crop protection, and digital products and services. With some of the most recognized brands in agriculture and a technology pipeline well positioned to drive growth, the company is committed to maximizing productivity for farmers, while

working with stakeholders throughout the food system as it fulfills its promise to enrich the lives of those who produce and those who consume, ensuring progress for generations to come. More information can be found at www.corteva.com.

Cautionary Statement on Forward-Looking Statements

This

press release contains certain forward-looking statements. Words such as “intend,” “will,” “plan,” “may,” “expect,” “see,” and “evaluate” and variations of such

words and similar future or conditional expressions are intended to identify forward-looking statements. Examples of forward-looking statements include, but are not limited to, Corteva’s intent to separate and its related expectations for New

Corteva and SpinCo. These forward-looking statements reflect management’s current expectations and are not guarantees of future performance and are subject to a number of risks and uncertainties, many of which are difficult to predict and

beyond Corteva’s control.

Important factors that may affect Corteva’s business and operations and that may cause actual results to differ

materially from those in the forward-looking statements include, but are not limited to, whether the objectives of the separation will be achieved; the terms, structure, benefits and costs of any action or transaction resulting from the separation;

the timing of any such separation or related action and whether any such separation will be consummated at all; the risk that the announcement of the intended separation could have an adverse effect on the ability of Corteva to retain and hire key

personnel and maintain relationships with customers, suppliers, employees, shareholders and other business relationships and on its operating results and business generally; the risk the separation could divert the attention and time of the

company’s management; the risk of

any unexpected costs or expenses resulting from the separation process or separation itself; and the risk of any litigation relating to the separation, as well as the risks and uncertainties

described in Corteva’s risk factors, as they may be amended from time to time, set forth in its filings with the U.S. Securities and Exchange Commission. Corteva disclaims and does not undertake any obligation to update, revise, or withdraw

any forward-looking statement in this press release, except as required by applicable law or regulation.

EX-99.2

Filename: d57201dex992.htm · Sequence: 4

EX-99.2

Exhibit 99.2

Corteva Announces Executive Leadership Team of its

Future Crop Protection Company

Indianapolis, Ind., April 14, 2026 – Corteva Inc. (NYSE: CTVA) announced today the executive leadership team that will lead “New Corteva,”

the publicly-traded, differentiated crop protection company resulting from the current company’s planned separation in the fourth quarter of 2026. This follows an earlier announcement naming Luke Kissam, former Albemarle Chairman, President

and CEO, as the New Corteva CEO. Luke will join the current company on June 1.

New Corteva will be innovation-driven in both its product portfolio and

its operating model, leveraging its technological leadership to deliver for farmers while also running an asset-light, efficient business. The company intends to make targeted investments to support growth and leverage its first-mover advantage in

nature-inspired technologies to pursue opportunities promising attractive returns in markets that reward differentiation.

“The business that will

become Corteva after separation, later this year, will lead a critical industry from a position of strength,” said Corteva Chair Greg Page, who will also chair New Corteva after separation. “I look forward to working with each of these

leaders to drive the new, focused company to even greater heights.”

“New Corteva’s success will be anchored in innovation and

sustainability, coupled with a laser focus on enterprise-wide operational excellence, and this team is the right team to help realize its bright future,” said Corteva CEO Chuck Magro. “It is an exciting time for the company, its leaders

and their future teams.”

The New Corteva executive leadership team will also assume their roles at separation, which is on track for

the fourth quarter of 2026. As follows:

•

Jeff Rudolph will be the company’s chief financial officer.

•

Brook Cunningham will be chief commercial officer.

•

Ralph Ford will be chief integrated operations officer.

•

Reza Rasoulpour will be chief technology officer.

•

Jim Alcombright will be chief digital and information officer.

•

The roles of chief legal officer and chief people officer are open, with internal and external

searches underway to fill them.

Robert King, current executive vice president of the Corteva Crop Protection business unit, will,

effective July 1, become a strategic advisor to the incoming New Corteva CEO, ensuring a smooth transition through separation for the entire leadership team. Robert will remain on the current Corteva ELT until separation, and after

separation, serve on the New Corteva ELT until the end of 2026, after which time he has elected to leave the company to pursue other leadership opportunities.

“I want to thank Robert for his invaluable leadership over the past few years, during which time we solidified our global leadership position in

Biologicals, launched more than a thousand products to help farmers protect their yields and delivered financial performance that consistently outperformed the industry,” said Magro. “We wish him the very best in his next chapter.”

Members of New Corteva executive leadership will be hosting an investor day on September 15 at the New York Stock Exchange; details on attendance

and participation will be shared in the coming weeks.

About Corteva

Corteva, Inc. (NYSE: CTVA) is a global pure-play agriculture company that combines industry-leading innovation, high-touch customer engagement and operational

Cautionary Statement on Forward-Looking Statements

This

press release contains certain forward-looking statements. Words such as “intend,” “will,” “plan,” “may,” “expect,” “see,” and “evaluate” and variations of such

beyond Corteva’s control.

Important factors that may affect Corteva’s business and operations and that may cause actual results to differ

company’s management; the risk of any unexpected costs or expenses resulting from the separation process or separation itself; and the risk of any litigation relating to the separation, as well as the risks and uncertainties described in

Corteva’s risk factors, as they may be amended from time to time, set forth in its filings with the U.S. Securities and Exchange Commission. Corteva disclaims and does not undertake any obligation to update, revise, or withdraw any

forward-looking statement in this press release, except as required by applicable law or regulation.

EX-99.3

Filename: d57201dex993.htm · Sequence: 5

EX-99.3

Exhibit 99.3

Corteva Announces Executive Leadership Team of its Future

Advanced Seed and Genetics Company

Indianapolis, Ind., April 14, 2026 – Corteva Inc. (NYSE: CTVA) announced today the executive leadership team that will lead “SpinCo,”

the publicly-traded, advanced seed and genetics company resulting from the current company’s planned separation in the fourth quarter of 2026.

The

SpinCo innovation engine will be anchored in the agriculture industry’s most elite germplasm and transformative biotech. The company will leverage its next generation scientific expertise in disciplines like gene editing and molecular

breeding to further strengthen its core business while exploring opportunities to expand to new row crops – and potentially beyond. SpinCo will scale these innovations using its leading routes-to-market and by significantly expanding its licensing business.

“I have every confidence that this

new leadership team comprises a team that will deliver durable growth to drive our new company’s success,” said Corteva CEO Chuck Magro, who will become the SpinCo CEO at separation. “And that success will be anchored in innovation

that helps farmers grow more food – and fuel – underpinned by sustained investment in advanced technology, expanding our opportunity for impact, potentially even beyond row crops.”

The SpinCo executive leadership team will assume their roles at separation, which is on track for the fourth quarter of 2026. As follows:

•

David Johnson will be SpinCo chief financial officer.

•

Judd O’Connor will be chief commercial and operations officer.

•

Sam Eathington will be chief technology officer.

•

Audrey Grimm will be chief people officer.

•

Brian Lutz will be chief digital and information officer.

•

Jennifer Johnson will be chief legal officer.

Members of the SpinCo executive leadership will be hosting an investor day on September 15 at the New

York Stock Exchange; details on attendance and participation will be shared in the coming weeks, as will the name and brand of the new company.

About

Corteva

Corteva, Inc. (NYSE: CTVA) is a global pure-play agriculture company that combines industry-leading innovation, high-touch customer engagement

and operational execution to profitably deliver solutions for the world’s most pressing agriculture challenges. Corteva generates advantaged market preference through its unique distribution strategy, together with its balanced and globally

diverse mix of seed, crop protection, and digital products and services. With some of the most recognized brands in agriculture and a technology pipeline well positioned to drive growth, the company is committed to maximizing productivity for

farmers, while working with stakeholders throughout the food system as it fulfills its promise to enrich the lives of those who produce and those who consume, ensuring progress for generations to come. More information can be found at

www.corteva.com.

Cautionary Statement on Forward-Looking Statements

This press release contains certain forward-looking statements. Words such as “intend,” “will,” “plan,” “may,”

“expect,” “see,” and “evaluate” and variations of such words and similar future or conditional expressions are intended to identify forward-looking statements. Examples of forward-looking statements include, but

are not limited to, Corteva’s intent to separate and its related expectations for New Corteva and SpinCo. These forward-looking statements reflect management’s current expectations and are not guarantees of future performance and are

subject to a number of risks and uncertainties, many of which are difficult to predict and beyond Corteva’s control.

Important factors that may

affect Corteva’s business and operations and that may cause actual results to differ materially from those in the forward-looking statements include, but are not limited to, whether the objectives of the separation will be achieved; the terms,

structure, benefits and costs of any action or transaction resulting from the separation; the timing of any such separation or related action and whether any such separation will be consummated at all; the risk that the announcement of the intended

separation could have an adverse effect on the ability of Corteva to retain and hire key personnel and maintain relationships with customers, suppliers, employees, shareholders and other business relationships and on its operating results and

business generally; the risk the separation could divert the attention and time of the company’s management; the risk of any unexpected costs or expenses resulting from the separation process or separation itself; and the risk of any

litigation relating to the separation, as well as the risks and uncertainties described in Corteva’s risk factors, as they may be amended from time to time, set forth in its filings with the U.S. Securities and Exchange Commission. Corteva

disclaims and does not undertake any obligation to update, revise, or withdraw any forward-looking statement in this press release, except as required by applicable law or regulation.

GRAPHIC

Filename: g57201g0414070006162.jpg · Sequence: 10

Binary file (8741 bytes)

Download g57201g0414070006162.jpg

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 12

v3.26.1

Document and Entity Information

Apr. 14, 2026

Document Information [Line Items]

Document Type

8-K

Document Period End Date

Apr. 14, 2026

Entity Registrant Name

Corteva, Inc.

Entity Incorporation State Country Code

Entity File Number

001-38710

Entity Tax Identification Number

82-4979096

Entity Address Address Line 1

9330 Zionsville Road

Entity Address City Or Town

Indianapolis

Entity Address State Or Province

Entity Address Postal Zip Code

46268

City Area Code

833

Local Phone Number

267-8382

Written Communications

false

Soliciting Material

false

Pre Commencement Tender Offer

false

Pre Commencement Issuer Tender Offer

false

Security 12b Title

Common Stock, par value $0.01 per share

Trading Symbol

CTVA

Security Exchange Name

NYSE

Entity Emerging Growth Company

false

Amendment Flag

false

Entity Central Index Key

0001755672

Other Address [Member]

Document Information [Line Items]

Entity Address Address Line 1

974 Centre Road

Entity Address City Or Town

Wilmington

Entity Address State Or Province

Entity Address Postal Zip Code

19805

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:

dei_DocumentInformationLineItems

Namespace Prefix:

dei_

Data Type:

xbrli:stringItemType

Balance Type:

Period Type:

duration

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

Period Type:

duration

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

Period Type:

duration

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

Period Type:

duration

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

Period Type:

duration

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

Period Type:

duration

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

Period Type:

duration

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Details

Name:

dei_EntityAddressesAddressTypeAxis=dei_OtherAddressMember

Namespace Prefix:

Data Type:

Balance Type:

Period Type: